Jurubine



Compound IDCDAMM02621
Common nameJurubine
IUPAC name2-[4-(16-amino-6-hydroxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosan-6-yl)-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Molecular formulaC33H57NO8

Experimental data

Retention time14.84
Adduct[2M+Na]+
Actual mz1213.8
Theoretical mz1213.81
Error1.83
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.3135

Identifiers and class information

Inchi keyYEWUMIMAJWFDQG-UHFFFAOYNA-N
SmilesOCC1OC(OCC(C)CCC2(O)OC3CC4C5CCC6CC(N)CCC6(C)C5CCC4(C)C3C2C)C(O)C(O)C1O
SuperclassLipids and lipid-like molecules
ClassSteroids and steroid derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)4
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)13
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)595.815
Computed dipole moment(dipole)6.175
Total solvent accessible surface area (SASA)905.498
Hydrophobic component of SASA (FOSA)656.074
Hydrophilic component of SASA (FISA)249.424
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1810.09
Number of hydrogen bond donors (donorHB)7
Number of hydrogen bond acceptors (accptHB)12.7
Free energy of solvation of dipole (dip^2/V)0.0210683
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0371078
Globularity descriptor (glob)0.793251
Predicted polarizability in cubic angstroms (QPpolrz)57.938
Predicted hexadecane/gas partition coefficient (QPlogPC16)18.263
Predicted octanol/gas partition coefficient (QPlogPoct)36.809
Predicted water/gas partition coefficient (QPlogPw)23.489
Predicted octanol/water partition coefficient (QPlogPo/w)2.213
Predicted aqueous solubility (QPlogS)-4.289
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.732
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.604
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)10.654
Predicted brain/blood partition coefficient (QPlogBB)-2.464
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)4.038
Predicted skin permeability, log Kp (QPlogKp)-6.931
PM3 calculated ionization potential (IP(ev))9.407
PM3 calculated electron affinity (EA(eV))-1.953
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)0.239
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)32.375
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)156.425
Number of nitrogen and oxygen atoms (#NandO)9
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P08185SERPINA6Corticosteroid binding globulinT88452SEA
Q8TDU6GPBAR1G-protein coupled bile acid receptor 1T86273SEA
P11413G6PDGlucose-6-phosphate 1-dehydrogenaseT63484SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P60568IL2Interleukin-2T61698SEA
P60842EIF4A1Eukaryotic initiation factor 4A-IT86805SEA
O15439ABCC4Multidrug resistance protein 4T39919SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T88452DI0037Asthma[ICD-11: CA23]P08185SERPINA6
T88452DI0339Postoperative inflammation[ICD-11: 1A00-CA43]P08185SERPINA6
T88452DI0362Respiratory system disease[ICD-11: CB40-CB7Z]P08185SERPINA6
T86273DI0417Type 2 diabetes mellitus[ICD-11: 5A11]Q8TDU6GPBAR1
T63484DI0086Chronic obstructive pulmonary disease[ICD-11: CA22]P11413G6PD
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T86805DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P60842EIF4A1

Copyright © 2025